LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a 20-patient pilot clinical trial to examine the safety and ...

Those driving to work daily and spending more than two hours on the roads are at heightened risk for osteoporosis, according to experts. Doctors say sitting in one position and driving leads to ...

A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds. Levothyroxine — marketed under brand names such as Synthroid — is the ...